查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1825367

尼古丁口香糖市场：2025-2030 年预测

Nicotine Gum Market - Forecasts from 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 145 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

尼古丁口香糖市场预计将从 2025 年的 18.72 亿美元成长到 2030 年的 24.01 亿美元，复合年增长率为 5.11%。

尼古丁口香糖是一种非处方 (OTC) 戒烟辅助产品，旨在帮助人们减少烟草消费量，最终戒除烟草。它透过释放尼古丁，经由口腔黏膜吸收，进而缓解烟瘾、戒断症状和衝动。尼古丁口香糖有 2 毫克、4 毫克和 6 毫克三种规格，可根据个人每日烟草消费量进行客製化。全球尼古丁口香糖市场正经历成长，这得益于人们健康意识的增强、吸烟相关疾病的日益流行以及政府和非政府组织 (NGO) 的支持。然而，尼古丁口香糖的潜在副作用可能对市场扩张构成挑战。

市场趋势

尼古丁口香糖市场受多种关键趋势驱动。其中一个关键驱动因素是肺癌、冠状动脉心臟病、口咽癌、食道癌、中风、类风湿性关节炎、类风湿性关节炎和免疫相关疾病等吸烟相关疾病的发生率不断上升。人们对这些健康风险的认识不断提高，推动了对尼古丁口香糖等戒烟辅助产品的需求。此外，全球反吸烟宣传活动和公共卫生倡议，例如世界卫生组织 (WHO) 每年 5 月 31 日的世界无烟日，正在提高人们对烟草有害影响的认识，并鼓励人们采用戒烟产品。无烟儿童宣传活动等非政府组织进一步扩大了这些努力，并倡导在全球范围内减少烟草使用，从而推动了对尼古丁口香糖的需求。

推动市场成长的另一个趋势是戒烟疗法的日益普及。无论是在已开发市场或新兴市场，政府和非政府组织都在积极推广尼古丁口香糖，以帮助烟瘾者，尤其是青少年。尼古丁含片和口感柔滑的口香糖等产品创新也促进了市场成长。製造商正在加大研发投入，以丰富产品线，满足消费者对有效且易于使用的戒烟辅助剂的偏好。都市化的加速和健康意识的增强进一步推动了此类产品的需求。

驱动程式

尼古丁口香糖市场的发展受到强劲的戒烟倡议和越来越多尝试戒烟人士的推动。公众意识提升宣传活动和严格的禁烟法规正在推动戒烟辅助产品的需求。例如，世界无烟日和「无烟儿童宣传活动」等全球倡议旨在教育大众吸烟的健康风险，并鼓励使用尼古丁口香糖来抑制吸烟慾望。製造商正在透过推出创新产品（例如改良质地的含片和口香糖）来支持这些倡议，以满足不断变化的消费者需求。吸烟相关疾病（尤其是肺癌）的盛行率不断上升，进一步推动了对尼古丁口香糖的需求，将其作为减少烟草依赖的工具。

然而，尼古丁口香糖的副作用也可能导致市场面临潜在限制，这可能会限制部分消费者群体的接受度。儘管如此，在公共卫生宣传活动的支持下，全球戒烟试验的人数不断增加，这将继续推动市场成长。

地理视角

预计在整个预测期内，北美仍将是尼古丁口香糖的主要市场。美国在该地区占据主导地位，领先品牌专注于产品创新以满足日益增长的需求。例如，Nicorette 最近推出了口感更滑顺的尼古丁口香糖和冰薄荷润喉糖，以满足消费者对提升使用者体验的偏好。这些新兴市场的发展预计将维持北美市场的成长。

欧洲也占了相当大的市场份额，德国、英国、法国和义大利等国的销售强劲。各国政府正在优先考虑禁烟策略，这进一步推动了市场扩张。同时，预计亚太地区在预测期内的复合年增长率最高。推动这一成长的因素包括消费者对先进戒烟辅助产品的需求不断增长、烟草公司之间竞争加剧以及商业机会不断扩大。预计日本将引领该地区的成长，而中国和印度严格的禁烟法可能会刺激对尼古丁口香糖作为传统烟草产品替代品的需求。

尼古丁口香糖市场预计将在日益增强的健康意识、吸烟相关疾病发病率上升以及强有力的反吸烟倡议的推动下实现增长。北美和欧洲仍将是主要市场，而亚太地区预计将拥有强劲的成长潜力。儘管潜在的副作用带来挑战，但持续的研发和创新产品的推出预计将保持市场动能。为了抓住这些机会，产业相关人员应专注于利用公共卫生宣传活动并开发消费者友善产品。

本报告的主要优点

  • 深入分析：深入了解主要和新兴地区的市场洞察，重点关注客户群、政府政策和社会经济因素、消费者偏好、垂直行业和其他细分市场。
  • 竞争格局：了解主要企业所采用的策略策略，并了解采用正确策略的市场渗透潜力。
  • 市场趋势和驱动因素：探索动态因素和关键市场趋势以及它们将如何影响未来的市场发展。
  • 可行的建议：利用洞察力来制定策略决策，在动态环境中开闢新的业务流和收益。
  • 受众广泛：对于新兴企业、研究机构、顾问、中小企业和大型企业来说，既有利又划算。

它有什么用途？

产业和市场考量、商业机会评估、产品需求预测、打入市场策略、地理扩张、资本投资决策、法律规范与影响、新产品开发、竞争影响

调查范围

  • 2022 年至 2024 年的历史数据和 2025 年至 2030 年的预测数据
  • 成长机会、挑战、供应链前景、法律规范与趋势分析
  • 竞争定位、策略和市场占有率分析
  • 收益成长和预测细分市场和区域分析（包括国家）
  • 公司概况（尤其是财务状况和关键发展）。

目录

第一章执行摘要

第二章市场概述

  • 市场概况
  • 市场定义
  • 调查范围
  • 市场区隔

第三章 经营状况

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 波特五力分析
  • 产业价值链分析
  • 政策法规
  • 策略建议

第四章 技术展望

5. 尼古丁口香糖市集（按剂量）

  • 介绍
  • 2mg
  • 4mg

6. 尼古丁口香糖市集（依通路）

  • 介绍
  • 在线的
  • 离线
    • 超级市场/大卖场
    • 便利商店
    • 药局

第七章 尼古丁口香糖市集（依年龄层）

  • 介绍
  • 18至30岁
  • 30至50岁
  • 50岁或以上

8. 尼古丁口香糖市集（依地区）

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 其他的
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 其他的
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 印尼
    • 泰国
    • 其他的

第九章竞争格局及分析

  • 主要企业和策略分析
  • 市占率分析
  • 合併、收购、协议和合作
  • 竞争对手仪表板

第十章：公司简介

  • GlaxoSmithKline Plc
  • Johnson and Johnson
  • ITC Limited
  • Cipla
  • Perrigo Company Plc
  • Fertin Pharma
  • Alchem International
  • Haleon Group
  • Dr. Reddy's Laboratories Ltd.
  • British American Tobacco plc

第十一章 附录

  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要利益
  • 调查方法
  • 简称
简介目录
Product Code: KSI061614362

The Nicotine Gum Market is expected to grow from USD 1.872 billion in 2025 to USD 2.401 billion in 2030, at a CAGR of 5.11%.

Nicotine gum serves as an over-the-counter (OTC) smoking cessation aid designed to assist individuals in reducing cigarette consumption and ultimately quitting tobacco use. By releasing nicotine absorbed through the oral mucosa, the gum helps alleviate cravings, withdrawal symptoms, and the urge to smoke. Available in 2 mg, 4 mg, and 6 mg strengths, the dosage is tailored to an individual's daily cigarette consumption. The global nicotine gum market is experiencing growth driven by rising health consciousness, increasing prevalence of smoking-related diseases, and supportive initiatives from governments and non-governmental organizations (NGOs). However, potential adverse effects of nicotine gum may pose challenges to market expansion.

Market Trends

The nicotine gum market is propelled by several key trends. A significant driver is the growing incidence of smoking-related illnesses, such as lung cancer, coronary heart disease, oropharyngeal and esophageal cancers, stroke, rheumatoid arthritis, tuberculosis, and immune-related disorders. Heightened awareness of these health risks has increased demand for smoking cessation aids like nicotine gum. Additionally, global anti-smoking campaigns and public health initiatives, such as the World Health Organization's "World No Tobacco Day" observed annually on May 31, promote awareness of tobacco's adverse effects and encourage the adoption of cessation products. NGOs like the Campaign for Tobacco-Free Kids further amplify these efforts, driving demand for nicotine gum by advocating for reduced tobacco use worldwide.

Another trend fueling market growth is the increasing adoption of smoking cessation therapies. Governments and NGOs in both developed and emerging markets are actively promoting nicotine gum to support tobacco-addicted individuals, particularly younger demographics. Product innovation, such as the development of nicotine lozenges and smoother-textured gums, also contributes to market expansion. Manufacturers are investing in research and development (R&D) to enhance product offerings, aligning with consumer preferences for effective and user-friendly cessation aids. Urbanization and rising health consciousness further bolster demand for these products.

Growth Drivers

The nicotine gum market is driven by robust anti-smoking initiatives and the growing number of individuals attempting to quit smoking. Public awareness campaigns and stringent anti-smoking regulations have heightened the demand for cessation aids. For example, global initiatives like World No Tobacco Day and the Campaign for Tobacco-Free Kids educate the public on smoking's health risks, encouraging the use of nicotine gum to manage cravings. Manufacturers support these efforts by introducing innovative products, such as lozenges and gums with improved textures, to meet evolving consumer needs. The rising prevalence of smoking-related diseases, particularly lung cancer, further drives demand for nicotine gum as a tool to reduce tobacco dependency.

However, the market faces potential constraints due to the adverse effects associated with nicotine gum, which may limit its adoption in some consumer segments. Despite this, the increasing number of quit attempts globally, supported by public health campaigns, continues to drive market growth.

Geographical Outlook

North America is projected to remain the leading market for nicotine gum throughout the forecast period, driven by a growing base of health-conscious consumers and supportive government initiatives. The United States dominates this region, with major brands focusing on product innovation to meet rising demand. For instance, Nicorette recently introduced a smoother-textured nicotine gum and an ice mint lozenge, catering to consumer preferences for enhanced user experience. These developments are expected to sustain market growth in North America.

Europe also holds a significant market share, with strong sales in countries such as Germany, the United Kingdom, France, and Italy. Regional governments are prioritizing smoking cessation strategies, further supporting market expansion. Meanwhile, the Asia Pacific region is anticipated to experience the highest compound annual growth rate (CAGR) over the forecast period. Factors driving this growth include increasing consumer demand for advanced cessation products, heightened competition among tobacco companies, and expanding commercial opportunities. Japan is expected to lead regional growth, while stringent anti-smoking laws in China and India are likely to boost demand for nicotine gum as an alternative to traditional tobacco products.

The nicotine gum market is poised for growth, driven by rising health awareness, increasing smoking-related illnesses, and robust anti-smoking initiatives. North America and Europe remain key markets, while Asia Pacific is expected to exhibit strong growth potential. Despite challenges from potential side effects, ongoing R&D and innovative product launches are likely to sustain market momentum. Industry stakeholders should focus on leveraging public health campaigns and developing consumer-friendly products to capitalize on these opportunities.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Nicotine Gum Market Segments:

By Dosage Type

  • 2 Mg
  • 4 Mg

By Distribution Channel

  • Online
  • Offline
  • Supermarket/Hypermarket
  • Convenience Stores
  • Pharmacies

By Age

  • 18 to 30 Years
  • 30 to 50 Years
  • Greater than 50 Years

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. NICOTINE GUM MARKET BY DOSAGE TYPE

  • 5.1. Introduction
  • 5.2. 2 Mg
  • 5.3. 4 Mg

6. NICOTINE GUM MARKET BY DISTRIBUTION CHANNEL

  • 6.1. Introduction
  • 6.2. Online
  • 6.3. Offline
    • 6.3.1. Supermarket/Hypermarket
    • 6.3.2. Convenience Stores
    • 6.3.3. Pharmacies

7. NICOTINE GUM MARKET BY AGE

  • 7.1. Introduction
  • 7.2. 18 to 30 Years
  • 7.3. 30 to 50 Years
  • 7.4. Greater than 50 Years

8. NICOTINE GUM MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. USA
    • 8.2.2. Canada
    • 8.2.3. Mexico
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentina
    • 8.3.3. Others
  • 8.4. Europe
    • 8.4.1. Germany
    • 8.4.2. France
    • 8.4.3. United Kingdom
    • 8.4.4. Spain
    • 8.4.5. Others
  • 8.5. Middle East and Africa
    • 8.5.1. Saudi Arabia
    • 8.5.2. UAE
    • 8.5.3. Israel
    • 8.5.4. Others
  • 8.6. Asia Pacific
    • 8.6.1. China
    • 8.6.2. India
    • 8.6.3. Japan
    • 8.6.4. South Korea
    • 8.6.5. Indonesia
    • 8.6.6. Thailand
    • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. GlaxoSmithKline Plc
  • 10.2. Johnson and Johnson
  • 10.3. ITC Limited
  • 10.4. Cipla
  • 10.5. Perrigo Company Plc
  • 10.6. Fertin Pharma
  • 10.7. Alchem International
  • 10.8. Haleon Group
  • 10.9. Dr. Reddy's Laboratories Ltd.
  • 10.10. British American Tobacco plc

11. APPENDIX

  • 11.1. Currency
  • 11.2. Assumptions
  • 11.3. Base and Forecast Years Timeline
  • 11.4. Key benefits for the stakeholders
  • 11.5. Research Methodology
  • 11.6. Abbreviations